Sr. Director, Medical Affairs Lead (Pulmonary Fibrosis - Pulmonologists)(Remote) (Ridgefield, CT, United States, Connecticut)

Compensation

The base salary range for this position is $220,000 to $350,000.   The position may be eligible for a role specific discretionary bonus, relocation, and/or other compensation elements.  We continuously review market data and may adjust salary ranges as needed in the future.  Actual compensation will be based on job-related factors such as skills, experience, and qualifications, and other factors permitted by law. For an overview of our benefits please click here. Please reach out to Talent Acquisition or your HR Business Partner for more information. 

Description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

The Medical Affairs Lead is responsible for driving scientific readiness and stakeholder engagement to enable a TA/Brand/Asset’s success across its lifecycle. This role provides strategic leadership for a Medical Affairs team and serves as the Medicine representative within local asset teams, ensuring integrated evidence generation, education, and engagement strategies that empower healthcare professionals and patients

The Lead can function as a dual role; leading an expanding team of medical affairs strategy team members, and act as the medicine representative for local TA/Brand/Asset teams. 

Executes tactics on local TA/Brand/asset, with 1-3 indications, or includes company’s priority and/or novel TA/indications within the next 5yrs;

Strategically structures the planning across novel indications and patient populations  within a complex medical landscape, including 1-3 specialties across all stages of development in order to drive launch success;

Collaborates, partners, and engages with Global TA leadership forums (Regions for CPC, Global Brand Teams, TA Pipeline Medical Affairs) 

Oversees and aligns matrix structures across Medical Affairs functions, ensuring seamless coordination of priorities, resources, and deliverables within a highly cross-functional environment. 

The Lead can serve as a key member and leader within the TA/CDMA Leadership Team. This role is accountable for shaping and driving the overall Medical Affairs strategy for the assigned local TA/Brand/Asset, ensuring seamless alignment with the broader Therapeutic Area objectives. The Lead collaborates closely with other TA Medical Affairs leaders to deliver an integrated, cross-functional approach that supports evidence generation, and scientific engagement strategies.

The role does this by bringing together therapeutic area landscape knowledge, US healthcare dynamics, and medical affairs experience to translate TA/Brand/Asset US medical needs, gaps, and value drivers into an integrated strategic plan, budget, and tactics that enables the medical affairs role in the overall Boehringer-Ingelheim market approach, and informs clinical development efforts, where applicable. The Medical Affairs Lead collaborates cross- functionally and within the larger Clinical Development & Medical Affairs (CDMA) department (e.g., Medical Excellence, RWE, etc.) as well as across the organization (e.g., Marketing, Market Access, Analytics & Insights (A&I), HEOR, Clinical Operations, Patient Services, Legal, Compliance, etc.) and with global counterparts to create, execute, measure, and adapt the Medical Affairs strategy for all indications within or under a TA/Brand/Asset.

Duties & Responsibilities

• Leads the US TA co-creation with Corporate partners of the relevant Global Integrated Business Plans(IBPs) and ensures US strategic business needs for indications within or under a TA/Brand/Asset are are fully integrated into the global IBPs.    
• Leads the implementation of the Launch Excellence in Medical Affairs by driving robust TA medical dialogue with Corporate TA, Brand/Asset stakeholders, the US Launch Lead, RWE, FBM,and Medicine Excellence. 
• Drives the US collaboration with Corporate TA to create a consolidated medical strategy and integrated evidence plan for a Brand/Asset products/indication(s) that prioritizes innovation and addresses meaningful gaps internally and externally. 
• Effectively leads sub teams in the creation and execution of medical tactics, key data release activities, stays abreast of product indication(s) and paradigm shifts in clinical practice, and aligns with Boehringer-Ingelheim/CDMA objectives, clinical development pipeline and the evolving US healthcare landscape.  
• Identifies and promotes synergies throughout the Brand/Asset lifecycle by influencing US TA, Corporate medical, the US TA franchise, Commercial operations, Go-To-Market (GTM), and CDMA leaders. 
• Proactively partners with the Clinical Development Lead and the Early Asset TA Lead to ensure the prioritized US clinical practice dynamics are fully integrated into the Clinical Development programs.  
• Ensures success for TA/Brand/Asset indication(s) launches and the timely execution of prioritized evidence generation programs in collaboration with Corporate Medicine TA and US franchise leadership. 
• Proactively collaborates very closely with the respective Clinical Development counterparts to ensure integration of US medical affairs strategic insights and market dynamics into the appropriate clinical development governance processes and decisions.
• Collaborates and works closely with other Brand/Asset leads within the TA to share industry best practices, medical scientific knowledge, and Brand or Asset insights, to enhance team engagement and drive success for within TA.  
• Serves as leader and member of TA/CDMA Leadership Team, and key representative in strategic discussions with CDMA Leadership regarding a Brand/Asset to maximize business opportunities from a medical perspective, identify risks, assess the competitive landscape for Brand/Asset indication(s), and ensure appropriate collaboration occur with various business functions. 
• Leads the integration of insights, planning, execution, and analysis of evidence programs, creation and enhancement of content resources, maximizing medical communication channels and Strategic Engagement program with key experts, scientific leaders, and key institutions.  
• Leads and provides guidance to the indication sub-team within a Brand/Asset on strategic congress planning, medical education, advisory boards, publication strategies, scientific advancement grants, interface with professional societies relevant to TA/indication. 

Requirements

• Bachelor’s degree required, and in addition fulfill one of the following education levels:
  • Advanced degree (PharmD, NP, PA, Master’s, M.D., DO, Ph.D.)  
  • Combined BSc. with a MBA, or BSN with an MBA
  • Other medically qualified licensure (e.g., RPh, Respiratory Therapist)
• Minimum of 8+ years of experience within the pharmaceutical industry preferably in Medical Affairs roles  
• Minimum of 3+ years leading and developing people / scientific team; preferably in positions related to medical affairs strategy and operations; clinical expertise, knowledge of clinical development, and some relevant experience in the disease area within the pharmaceutical industry strongly preferred 
• Demonstrated experience with pharmaceutical drug development and the use of data analysis for strategy development, business process improvement, product launch planning, and integrated evidence generation required 
• Ability to collaborate, influence, and lead with executive presence, establishing strategic direction, drive execution, create compelling communications and provide a global perspective 
• Ability to translate scientific and medical market insights into medical tactical plans for effective launches of pharmaceutical products in the US, integrated evidence generation plans, and optimized medical strategies.  
• Demonstrated ability to collaborate cross-functionally to enable successful execution and deliver results in a deadline-driven environment while managing multiple priorities. 
• Deep understanding of the IPF/ILF therapeutic area, shifting US healthcare environment, medical, pharmaceutical and payor market dynamics, portfolio growth, and ability to manage multiple projects and identify risks in a fast-paced environment with a drive for results and sense of urgency to meet medical market needs. 
• Ability to travel with some overnights away from home as required by the nature of the role, approximately 25-35%, though subject to change.    

Eligibility Requirements:

• Must be legally authorized to work in the United States without restriction.
• Must be willing to take a drug test and post-offer physical (if required).
• Must be 18 years of age or older.

Desired Skills, Experience and Abilities

• Leads ad hoc TA/Brand/Asset specific US projects to drive key strategic initiatives that facilitate business agility, customer focus and ensure compliance standards are met.
• Ensures the effectiveness of TA/Brand/Asset budget management and planning activities to strengthen digital, hybrid and omnichannel growth  opportunities, ensures availability of prioritized content, as well as develops and tracks the associated agreed measurable business outcomes. Proactively engages with Medical Customer Experience, A&I, Impact and Data Enablement, and Capability Excellence teams to ensure seamless planning. 
• Actively contributes and represents CDMA TA/Brand/Asset team in internal business planning workshops and relevant strategic planning governance to ensure effective co-creation of appropriate, aligned, and integrated critical success factors, strategic imperatives, and their associated outcome measures (e.g., key performance indicators, metrics).